BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6182258)

  • 1. [Antitumor effects of human interferon on human tumors heterotransplanted into nude mice].
    Sawada M; Oshikane M; Matsui Y; Okudaira Y; Kawashima M; Iwanaga K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1559-65. PubMed ID: 6182258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of human lymphoblastoid interferon on human yolk sac tumors in nude mice.
    Sawada M; Matsui Y; Okudaira Y
    Biken J; 1983 Dec; 26(4):169-73. PubMed ID: 6204635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of human yolk sac tumor heterotransplanted in nude mice.
    Sawada M; Matsui Y; Okudaira Y
    J Natl Cancer Inst; 1983 Dec; 71(6):1221-5. PubMed ID: 6197552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy of yolk sac tumor heterotransplanted to nude mice (author's transl)].
    Sawada M; Hayakawa K; Matsui Y; Nishiura H; Okudaira Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1596-602. PubMed ID: 7240825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of a newly developed platinum compound cis-1, 1-cyclobutane dicarboxylato-(2R)-2-methyl-1,4-butane diamine platinum (II), on human ovarian tumors transplanted into nude mice].
    Sawada M; Ozaki M; Taniguchi H; Tateishi R; Mori Y; Mino K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):637-41. PubMed ID: 3355185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumor effects of high-dose cisplatin in hypertonic saline against human ovarian tumors heterotransplanted in nude mice].
    Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M; Koizumi K; Okamoto E
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1103-7. PubMed ID: 3611881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of cis-platinum diammine dichloride on yolk sac tumor transplanted in nude mice (author's transl)].
    Sawada M; Matsui Y; Nishiura H; Yagyu M; Hayakawa K; Okudaira Y; Kawashima M; Iwanaga K
    Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):519-24. PubMed ID: 7195137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential.
    Wang L; Tang ZY; Qin LX; Wu XF; Sun HC; Xue Q; Ye SL
    Hepatology; 2000 Jul; 32(1):43-8. PubMed ID: 10869287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice].
    Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M; Taniguchi H; Tateishi R; Mori Y
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):693-8. PubMed ID: 3548596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
    Heston WD; Fleischmann J; Tackett RE; Ratliff TL
    Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on human lymphoblastoid interferon-alpha (MOR-22): Part III. Antitumor effect on nude mouse-transplanted human tumors].
    Nobuhara M; Kanamori T; Harada Y; Horisawa Y; Ishii K; Yanagihara Y; Kiyonaga J
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):134-8. PubMed ID: 3753641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alpha and gamma interferons and cytostatics on ovarian cancer in the subrenal capsule assay.
    Grönroos M; Mäenpää J; Söderström KO; Kangas L; Leppänen M; Cantell K
    Med Biol; 1983; 61(5):275-9. PubMed ID: 6200736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of the establishing individual protocol for effective chemotherapy of ovarian cancer--fundamental research using human tumor-nude mouse system].
    Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct; 39(10):1776-83. PubMed ID: 3429976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antitumor effect of interferon against human choriocarcinoma cell lines].
    Sekiya S; Kaiho T; Shirotake S; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Nov; 34(11):1827-32. PubMed ID: 6890971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein.
    Liang ZH; Wu PH; Li L; Xue G; Zeng YX; Huang WL
    Chin Med J (Engl); 2004 Dec; 117(12):1809-14. PubMed ID: 15603709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon gamma is highly effective against orthotopically-implanted human pleural adenocarcinoma in nude mice.
    An Z; Wang X; Astoul P; Danays T; Moossa AR; Hoffman RM
    Anticancer Res; 1996; 16(5A):2545-51. PubMed ID: 8917349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of interferon-omega: in vivo therapy of human tumor xenografts in nude mice.
    Horton HM; Hernandez P; Parker SE; Barnhart KM
    Cancer Res; 1999 Aug; 59(16):4064-8. PubMed ID: 10463608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human yolk sac tumor of the thymus heterotransplanted into nude mice].
    Takao S; Nishi M; Baba K; Arimura T; Maenohara S; Mitani M; Kaneko Y; Nomura H; Suganuma T
    Gan No Rinsho; 1983 Oct; 29(12):1398-408. PubMed ID: 6196499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Yolk Sac Tumor of the Ovary Serially Heterotransplanted in nude mice.
    Sawada M; Hayakawa K; Nishiura H; Matsui Y; Tanabe S
    Gynecol Oncol; 1981 Feb; 11(1):29-43. PubMed ID: 6162720
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth inhibition of human osteosarcomas in nude mice by human interferon-alpha: significance of dose and tumor differentiation.
    Brosjö O; Bauer HC; Broström LA; Nilsson OS; Reinholt FP; Tribukait B
    Cancer Res; 1987 Jan; 47(1):258-62. PubMed ID: 3466689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.